Company profile: eTheRNA Immunotherapies
1.1 - Company Overview
Company description
- Provider of mRNA and lipid nanoparticle solutions for nucleic acid drug delivery, offering LNP platforms and customized LNP development using proprietary ionizable lipid libraries, plus LNP formulations for systemic cancer vaccines, intra-tumoral immuno-oncology, intramuscular prophylactic vaccines, and autoimmune diseases designed to maximize mRNA expression, efficacy, tolerability, and immune tolerance.
Products and services
- Customized LNP Development: etherna architects custom-engineered lipid nanoparticles (cLNPs) for specific therapeutic applications using proprietary ionizable lipid libraries, protecting nucleic acid payloads and enabling targeted delivery to intended sites of action
- LNP Platforms: etherna engineers targeted-delivery lipid nanoparticle platforms for nucleic acid drug transport, shielding active payloads from degradation and ensuring delivery to the intended site of action
- Prophylactic Vaccines: etherna constructs intramuscular-administered LNP formulations using novel ionizable lipids, maximizing local mRNA expression with good tolerability and safety for preventive vaccination applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to eTheRNA Immunotherapies
Rovers
HQ: The Netherlands
Website
- Description: Provider of cancer-screening medical devices, designing, developing, and manufacturing self-sampling and diagnostic tools including Evalyn Brush for at-home HPV screening; Anex Brush for anal cancer screening; Orcellex Brush for oral cancer screening; Viba-Brush and Delphi Screener for cervical cancer self-sampling; and Cervex-Brush for comprehensive cervical cell collection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rovers company profile →
Capintec
HQ: United States
Website
- Description: Provider of calibration and measurement technologies for nuclear medicine applications, offering advanced technology and services with a commitment to continuous quality improvement, including the Captus® 4000e Thyroid Uptake System for measuring thyroid uptake.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Capintec company profile →
IOmet Pharma
HQ: United Kingdom
Website
- Description: Provider of novel small-molecule medicines for the treatment of cancer, discovered and developed in the UK with particular emphasis on cancer immunotherapy and cancer metabolism.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IOmet Pharma company profile →
QT Imaging
HQ: United States
Website
- Description: Provider of breast imaging services via tomographic transmission ultrasound, offering non-invasive 3D imaging without contrast agents or radiation. Products include the Breast Acoustic CT System, QTscan, and an AI-enabled diagnostic platform leveraging transmission and reflection modalities, plus QT Imaging 3D technology for tissue-specific microanatomy and 3D Acoustic CT for potential whole-body diagnostics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QT Imaging company profile →
Varian
HQ: United States
Website
- Description: Provider of medical devices and software for treating cancer and other conditions via radiotherapy, radiosurgery, proton therapy, and brachytherapy. Offers informatics software; products such as Ethos Adaptive Radiotherapy System, IntelliBlate Microwave Ablation System, Laguna Thrombectomy System, and Varian Marketplace, plus Advanced Oncology Solutions providing clinical and professional support and workflow solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Varian company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for eTheRNA Immunotherapies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to eTheRNA Immunotherapies
2.2 - Growth funds investing in similar companies to eTheRNA Immunotherapies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for eTheRNA Immunotherapies
4.2 - Public trading comparable groups for eTheRNA Immunotherapies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →